Skip to main content

GE HealthCare Technologies Inc

For the period ended Jun 30, 2024. Filed Jul 31, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Jul 31, 2024

GEHC$83.65-0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Income

Condensed Consolidated Statements of Income (Unaudited)
For the three months ended June 30For the six months ended June 30
(In millions, except per share amounts)2024202320242023
Sales of products$3,207$3,213$6,253$6,344
Sales of services1,6321,6043,2373,180
Total revenues4,8394,8179,4899,524
Cost of products2,0452,0844,0124,121
Cost of services7927931,5741,572
Gross profit2,0021,9403,9043,831
Selling, general, and administrative1,0671,0722,1052,134
Research and development327298651568
Total operating expenses1,3951,3702,7562,702
Operating income6085701,1481,129
Interest and other financial charges – net131137254273
Non-operating benefit (income) costs(101)(123)(204)(238)
Other (income) expense – net(1)(14)8(22)
Income before income taxes5785701,0901,116
Benefit (provision) for income taxes(143)(137)(267)(300)
Net income435433823816
Net (income) loss attributable to noncontrolling interests(7)(15)(21)(26)
Net income attributable to GE HealthCare428418802790
Deemed preferred stock dividend of redeemable noncontrolling interest———(183)
Net income attributable to GE HealthCare common stockholders$428$418$802$607
Earnings per share attributable to GE HealthCare common stockholders:
Basic$0.94$0.92$1.76$1.34
Diluted$0.93$0.91$1.75$1.33
Weighted-average number of shares outstanding:
Basic457455456455
Diluted459458459458
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.